<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04272931</url>
  </required_header>
  <id_info>
    <org_study_id>NL71535.068.19</org_study_id>
    <nct_id>NCT04272931</nct_id>
  </id_info>
  <brief_title>DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Combined PVE/HVE</brief_title>
  <acronym>DRAGON</acronym>
  <official_title>DRAGON 1- Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization to Accelerate Future Liver Remnant (FLR) Hypertrophy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Koningin Wilhelmina Fonds</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Brief Summary: Some colorectal liver metastases can only be resected after inducing liver&#xD;
      regeneration by portal vein embolization (PVE) to increase size function of the future liver&#xD;
      remnant (FLR). While PVE is standard, embolization of portal vein and hepatic veins (PVE/HVE)&#xD;
      on one side of the liver may faster and more extensive liver size and function growth.&#xD;
      PVE/HVE is a novel procedure and requires a safety and feasibility evaluation in a pretrial&#xD;
      (DRAGON1) to then be compared in a randomized controlled trial (RCT) to PVE (DRAGON 2).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Detailed Description: Resection of liver metastases from colorectal cancer (CRLM) improves&#xD;
      survival compared to chemotherapy alone and may lead to cure in up to 40% of patients.&#xD;
      Surgical resectability is limited by location of metastases and by FLR size and function.&#xD;
      Commonly, the volume of the future liver remnant (FLR) should be at least 30% of the&#xD;
      functional FLR volume. If this volume criterion is not met, the induction of liver&#xD;
      regeneration between a two-stage hepatectomy is performed at many centers, with the aim to&#xD;
      render patients resectable and reduce the risk of post hepatectomy liver failure. Gold&#xD;
      standard to induce regeneration is the embolization of the portal vein branches to the tumor&#xD;
      carrying liver (PVE) to induce regeneration of the FLR. Recently, combined embolization of&#xD;
      both portal and hepatic veins (PVE/HVE) has been described as an alternative to portal vein&#xD;
      embolization because it accelerates and increases growth of the FLR. PVE/HVE combines&#xD;
      simultaneous embolization of the portal main branches into the tumor bearing liver and the&#xD;
      hepatic vein draining them. The tissue in the part of the liver treated with PVE/HVE stays&#xD;
      viable because the hepatic artery continues to supplies the liver deprived of portal and&#xD;
      hepatic veins. Preclinical studies in pigs have demonstrated feasibility of this method and&#xD;
      human case series show accelerated and increased liver growth. No multi-center evaluation has&#xD;
      been performed so far. DRAGON 1 is an international, prospective, multi-center trial to test&#xD;
      enrolment capacity of participants and safety of portal and hepatic vein embolization&#xD;
      (PVE/HVE). DRAGON 1 will form the basis of the RCT DRAGON 2 to compare PVE with PVE/HV.&#xD;
      DRAGON 2 is expected to start in 2021.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 8, 2020</start_date>
  <completion_date type="Anticipated">May 7, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 7, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <intervention_model_description>Multicenter, international, prospective, multi-center trial to test enrolment capacity of participants and safety of Portal and Hepatic Vein Embolization (PVE/HVE): DRAGON 1 will form the basis of a planned subsequent trial (&quot;DRAGON 2&quot;) that will compare PVE with PVE/HVE. In DRAGON 1 every center has to demonstrate the ability to enroll 3 patients in 12 months safely</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Ability of each center to enroll 3 patients in 12 months without mortality due to the intervention.</measure>
    <time_frame>1 year/ 90 day mortality</time_frame>
    <description>Ability of each center to enroll 3 patients for PVE/HVE in 12 months safely and perform the procedure including the liver resection without 90-day mortality after resection due to complications. If this goal is achieved center will be enrolled in DRAGON 2.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Efficacy assessment: standardized future liver remnant volume</measure>
    <time_frame>6 weeks</time_frame>
    <description>Increased of standardized future liver remnant volume between initial imaging and imaging at 1 week, 3 weeks, 6 weeks, degree of hypertrophy based on standard future liver remnant volume, kinetic growth</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Feasibility assessment: resection rate</measure>
    <time_frame>1 year follow up</time_frame>
    <description>ion of patients proceeding to complete resection (=resection rate)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality assessment</measure>
    <time_frame>90 days</time_frame>
    <description>90-mortality after resection</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall survival after PVE/HVE</measure>
    <time_frame>1 year follow up</time_frame>
    <description>Overall survival</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oncological effectiveness of PVE/HVE</measure>
    <time_frame>1 year</time_frame>
    <description>Disease-free survival after 1 year</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>General complication assessment</measure>
    <time_frame>90 days</time_frame>
    <description>90-day complications, general (Clavien-Dindo)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Liver specific complication assessment</measure>
    <time_frame>90 days</time_frame>
    <description>90-day complications, liver specific (FABIB-classification)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">125</enrollment>
  <condition>Colorectal Cancer Liver Metastases</condition>
  <arm_group>
    <arm_group_label>Portal and Hepatic Vein Embolization</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 patients per center over one year approximately 90 patients in total. Patients will undergo portal vein and hepatic vein embolization instead of only portal vein embolization.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Portal and Hepatic Vein Embolization</intervention_name>
    <description>Procedure/Surgery: Combined portal vein embolization and hepatic vein embolization (PVE/HVE) • All techniques of PVE allowed (ipsi-lateral, contra-lateral, trans-splenic, all embolization agents except for ethanol alone) • All modifications of HVE allowed (venous occlusion umbrellas; trans-jugular, trans-hepatic, no use of vein glue to avoid lung embolization; staged approach allowed, but first PVE, then HVE and within 48 hours)</description>
    <arm_group_label>Portal and Hepatic Vein Embolization</arm_group_label>
    <other_name>Liver venous deprivation (LVD)</other_name>
    <other_name>Double embolization</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with primarily unresectable/potentially resectable CRLM after conversion&#xD;
             chemotherapy with a FLR &lt;30% in normal livers, or 40% in livers chemotherapy damaged&#xD;
             livers.&#xD;
&#xD;
          -  18 years and older&#xD;
&#xD;
          -  Patients up to ECOG 3 (not more than 50% bedbound)&#xD;
&#xD;
          -  Patients with non-resected primary colorectal cancer (CRC) may be included if and only&#xD;
             if there is an intent to remove the CRC after the liver treatment (liver first&#xD;
             approach)&#xD;
&#xD;
          -  Staging CT chest and (if symptomatic) CT/MRI excludes unresectable extrahepatic&#xD;
             disease, while metastatic disease that may be cured in the future, is included.&#xD;
&#xD;
          -  Patients with resectable lung metastases or lung metastases that and be ablated can be&#xD;
             included only after statement about resectability/ablatability by tumor board&#xD;
&#xD;
          -  Patients have to be to understand the trial and provide informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with extrahepatic disease other than lung metastases&#xD;
&#xD;
          -  Patients with metastatic disease to the lung that cannot be ablated or resected will&#xD;
             be excluded&#xD;
&#xD;
          -  Patients with intrahepatic Cholangiocarcinoma (IHCC)&#xD;
&#xD;
          -  Patients with Perihilar Cholangiocarcinoma (PHCC)&#xD;
&#xD;
          -  Patients with Hepatocellular Carcinoma (HCC)&#xD;
&#xD;
          -  Pregnant or lactating women will not be eligible&#xD;
&#xD;
          -  Potential to get pregnant has to be excluded (obligatory contraception etc.)&#xD;
&#xD;
          -  Progression by modified RECIST criteria on cross-sectional imaging after conversion&#xD;
             chemotherapy is an exclusion criterion. Complete response in cross-sectional imaging&#xD;
             after conversion chemotherapy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronald M van Dam, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Erik Schadde, MD FACS FEBS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Kantonsspital Winterthur/ Rush University Medical Center, Chicago</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Marc AH Bemelmans, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christiaan van der Leij, MD PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maastricht University Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christoph A Binkert, Prof.Dr.Med</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cantonal Hospital Winterthur</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Remon Korenblik, MD</last_name>
    <phone>+31 637297507</phone>
    <email>remon.korenblik@mumc.nl</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ronald M. van Dam, MD, PhD</last_name>
    <email>r.van.dam@mumc.nl</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Yale School of Medicine</name>
      <address>
        <city>New Haven</city>
        <state>Connecticut</state>
        <zip>06510</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>David C Madoff, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Kristin DeFrancesco</last_name>
    </contact_backup>
    <investigator>
      <last_name>David C Madoff, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kristin DeFrancesco</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Rush University Medical Center</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erik Schadde, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Jordan C Tasse, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Erik Schadde, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jordan C Tasse, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sam G Pappas, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bulent Arslan, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ashiq Masood, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karl Villanueva</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Karie Karolinski</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>T. Peter Kingham, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Juan C Camacho, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>T. Peter Kingham, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Juan C Camacho, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alicia N Lashley</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Camperdown</city>
        <state>New South Wales</state>
        <zip>NSW 2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Oliver Fisher, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Christopher Rogan, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Oliver Fisher, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christopher Rogan, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michael Crawford, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Steffens, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Monash Health, Clayton</name>
      <address>
        <city>Clayton</city>
        <state>Victoria</state>
        <zip>VIC 3168</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Diederick de Boo, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Daniel Croagh, MD PhD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Social Medical Center, South</name>
      <address>
        <city>Vienna</city>
        <zip>1100</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thomas Gruenberger, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Tanja Friz, BSc</last_name>
    </contact_backup>
    <investigator>
      <last_name>Thomas Gruenberger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tony Padickakudy</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tanja Fritz</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ivan Baclija</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hôpital Erasme</name>
      <address>
        <city>Brussels</city>
        <state>Bruxelles</state>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerio Lucidi, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Viviane van Laethem</last_name>
    </contact_backup>
    <investigator>
      <last_name>Valerio Lucidi, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Illario Tancredi, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>viviane van Laethem</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU-UCL Namur site Godinne</name>
      <address>
        <city>Yvoir</city>
        <state>Namen</state>
        <zip>5530</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Aelxandra Dili, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Claude Bertrand, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Alexandra Dili, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jean- François De Wispelaere, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claude Bertrand, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CHU de Liège</name>
      <address>
        <city>Liège</city>
        <zip>4000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Celine Lambrecht</last_name>
    </contact>
    <contact_backup>
      <last_name>Olivier Detry</last_name>
    </contact_backup>
    <investigator>
      <last_name>Celine Lambrecht</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Olivier Detry, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laurent Gérard, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Ottawa Hospital</name>
      <address>
        <city>Ottawa</city>
        <state>Ontario</state>
        <zip>k1H 8L6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Guillaume Martel, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Stephen Ryan, MD, PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Guillaume Martel, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen Ryan, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Aklile Workneh</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Klinikum Saarbrücken gGmbH</name>
      <address>
        <city>Saarbrücken</city>
        <state>Saarland</state>
        <zip>66119</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>habil. Gregor A Stavrou, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Elmar Spüntrup, Prof.dr.</last_name>
    </contact_backup>
    <investigator>
      <last_name>habil. Gregor A Stavrou, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Elmar Spüntrup, Prof. dr.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Halle (Saale)</name>
      <address>
        <city>Halle (Saale)</city>
        <state>Saksen-Anhalt</state>
        <zip>06120</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ulrich Ronellenfitsch, MD, Dr. med</last_name>
    </contact>
    <contact_backup>
      <last_name>Jörg Kleeff, MD, Dr. med</last_name>
    </contact_backup>
    <investigator>
      <last_name>Ulrich Ronellenfitsch, MD Dr. Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jörg Kleeff, MD Dr. Med</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Walter A Wohlgemuth, MD Dr. Med</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Zhanna Svatko</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Policlinico Sant'Orsola-Malpighi</name>
      <address>
        <city>Bologna</city>
        <zip>40138</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Matteo Serenari, MD phD</last_name>
    </contact>
    <contact_backup>
      <last_name>Alberta Capelli, MD phD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Matteo Serenari, MD phD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Alberta Capelli, MD phD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Poliambulanza</name>
      <address>
        <city>Brescia</city>
        <zip>25124</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mohammad Abu Hilal, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Claudio Salemmi, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Mohammad Abu Hilal, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claudio Salemmi, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>IRCCS San Raffaele Hospital</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Luca Aldrighetti, Prof</last_name>
    </contact>
    <contact_backup>
      <last_name>Stephanie Steidler</last_name>
    </contact_backup>
    <investigator>
      <last_name>Luca Aldrighetti, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesco De Cobelli, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francesca Ratti, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Simone Gusmini, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Salvatore Lamarca, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephanie Steidler</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Fondazione Policlinico Universitario Agostino Gemelli IRCCS</name>
      <address>
        <city>Roma</city>
        <zip>00168 Roma</zip>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Felice Giuliante, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Roberto Iezzie, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Felice Giuliante, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roberto Iezzie, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Maastricht University Medical Center+</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6229 HX</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Remon Korenblik, MD</last_name>
      <phone>+31637297507</phone>
      <email>remon.korenblik@mumc.nl</email>
    </contact>
    <contact_backup>
      <last_name>Ronald M van Dam, MD, PhD</last_name>
      <email>r.van.dam@mumc.nl</email>
    </contact_backup>
    <investigator>
      <last_name>Ronald M van Dam, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marc HA Bemelmans, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Christiaan van der Leij, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Remon Korenblik, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bram Olij, BCs</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amsterdam UMC, location AMC</name>
      <address>
        <city>Amsterdam</city>
        <state>Noord-Holland</state>
        <zip>1105 AZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Joris I Erdmann, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Otto M van Delden, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Joris I Erdmann, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Otto M van Delden, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Erasmus Medical Center</name>
      <address>
        <city>Rotterdam</city>
        <state>Zuid-Holland</state>
        <zip>3015</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dirk J. Grünhagen, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Adriaan Moelker, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Drik J Grünhagen, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Adriaan Moelker, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Amsterdam Medical Centers, Location VUmc</name>
      <address>
        <city>Amsterdam</city>
        <zip>1081HV</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martijn R Meijerink, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Evelien Schouten</last_name>
    </contact_backup>
    <investigator>
      <last_name>Martijn R Meijerink, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Geert Kazemier, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan de Vries, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Evelien Schouten</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Medical Center Groningen</name>
      <address>
        <city>Groningen</city>
        <zip>9713 GZ</zip>
        <country>Netherlands</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marieke T de Boer, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Jan T Bottema</last_name>
    </contact_backup>
    <investigator>
      <last_name>Marieke T de Boer, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Koert P de Jong</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Reinhoud PH Bokkers</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jan T Bottema</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Leanne van der Plas - Kemper</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Oslo University Hospital</name>
      <address>
        <city>Oslo</city>
        <zip>0450 Oslo</zip>
        <country>Norway</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Åsmund A Fretland, MD PhD</last_name>
      <phone>004795874542</phone>
    </contact>
    <contact_backup>
      <last_name>Ulrik Carling, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Åsmund A Fretland, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ulrik Carling, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Germans Trias I Pujol</name>
      <address>
        <city>Badalona</city>
        <state>Barcelona</state>
        <zip>08916 Badalona</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jordi Navinés López, MD PhD</last_name>
    </contact>
    <investigator>
      <last_name>Jordi Jordi Navinés López, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Esteban Cugat Andorra, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jaume Sampere Moragues, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Parc Taulí</name>
      <address>
        <city>Sabadell</city>
        <state>Barcelona</state>
        <zip>08208</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Arantxa Gelabert, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Francisco J Garcia Borobia, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Arantxa Gelabert</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Francisco J Garcia Borobia</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Mútua Terrassa</name>
      <address>
        <city>Terrassa</city>
        <state>Barcelona</state>
        <zip>08221</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Herrero, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Josep Guitart, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Erik Herrero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Josep Guitart, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitari Dr. Josep Trueta</name>
      <address>
        <city>Girona</city>
        <state>Gerona</state>
        <zip>17007</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jaume Codina Font, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Santi Lopez Ben</last_name>
    </contact_backup>
    <investigator>
      <last_name>Jaume Codina font, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Santi Lopez Ben, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Margarida Casellas, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clínic de Barcelona</name>
      <address>
        <city>Barcelona</city>
        <zip>08036</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Constantino Fondevilla, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Fernando Gómez, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Constantino Fondevilla, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Fernando Gómez, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yiliam Fundora, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Silvia Fernandez</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Miguel Servet</name>
      <address>
        <city>Zaragoza</city>
        <zip>50009</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alejandro Serrablo, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Luis Sarria, Md PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Alejandro Serrablo, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joaquin Medrano, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Luis Luis Sarria, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Linköping University Hospital</name>
      <address>
        <city>Linköping</city>
        <zip>581 85</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Per Sandström, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Bergthor Bjornsson, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Per Sandström, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bergthor Bjornsson, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Margareta Ahle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Lindhoff Larsson</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Karolinska University Hospital</name>
      <address>
        <city>Stockholm</city>
        <zip>14186</zip>
        <country>Sweden</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ernesto Sparrelid, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Martin Delle, MD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Ernesto Sparrelid, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Delle, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Claraspital &amp; Clarunis University Hospital Basel</name>
      <address>
        <city>Basel</city>
        <state>Basel-Stadt</state>
        <zip>CH-4058</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Otto Kollmar, Prof.</last_name>
    </contact>
    <contact_backup>
      <last_name>Bettina Woelnerhanssen</last_name>
    </contact_backup>
    <investigator>
      <last_name>Otto Kollmar, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Hoffman, Prof.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gabriel Hess, Dr.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Bettina Woelnershanssen</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Kantonsspital Winterthur (KSW)</name>
      <address>
        <city>Winterthur</city>
        <zip>8401</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Erik Schadde, MD</last_name>
    </contact>
    <contact_backup>
      <last_name>Sabine Kern</last_name>
    </contact_backup>
    <investigator>
      <last_name>Chistoph A Binkert, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Erik Schadde, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>University Hospital Southampton</name>
      <address>
        <city>Southampton</city>
        <state>Hampshire</state>
        <zip>SO16 6YD</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sachin Modi, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>John Primrose, MD PhD</last_name>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Aintree University Hospital</name>
      <address>
        <city>Liverpool</city>
        <state>Merseyside</state>
        <zip>L9 7AL</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Raphael DÍaz-Nieto, MD PhD</last_name>
    </contact>
    <contact_backup>
      <last_name>Rob Davis, MD PhD</last_name>
    </contact_backup>
    <investigator>
      <last_name>Raphael Díaz-Nieto, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rob Davis, MD PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Robert Jones, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hassan Malik, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stephen Fenwick, MD PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Benjamin Chan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Gladys Madzamba</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>Austria</country>
    <country>Belgium</country>
    <country>Canada</country>
    <country>Germany</country>
    <country>Italy</country>
    <country>Netherlands</country>
    <country>Norway</country>
    <country>Spain</country>
    <country>Sweden</country>
    <country>Switzerland</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>January 7, 2020</study_first_submitted>
  <study_first_submitted_qc>February 14, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 17, 2020</study_first_posted>
  <last_update_submitted>August 30, 2021</last_update_submitted>
  <last_update_submitted_qc>August 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 31, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Future Liver Remnant</keyword>
  <keyword>Portal and Hepatic Vein Embolization</keyword>
  <keyword>Colorectal Liver Metastases</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasm Metastasis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

